Use of mesenchymal stem cell therapy in COVID-19 related strokes
Coronavirus disease 2019 (COVID-19) has affected a broad demographics, eliciting a more significant effect on specific groups such as males, African Americans, and Hispanic minorities. Treatment of COVID-19 often requires antiviral drugs or monoclonal antibodies. However, immunotherapies such as mes...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2023-01-01
|
| Series: | Neural Regeneration Research |
| Subjects: | |
| Online Access: | http://www.nrronline.org/article.asp?issn=1673-5374;year=2023;volume=18;issue=9;spage=1881;epage=1883;aulast=Rawat |
| _version_ | 1797866431823478784 |
|---|---|
| author | Mahika Rawat Chiao Ng Emaad Khan Rayyan A Shah Suha Ashfaq Ghaith A Bahader Zahoor A Shah |
| author_facet | Mahika Rawat Chiao Ng Emaad Khan Rayyan A Shah Suha Ashfaq Ghaith A Bahader Zahoor A Shah |
| author_sort | Mahika Rawat |
| collection | DOAJ |
| description | Coronavirus disease 2019 (COVID-19) has affected a broad demographics, eliciting a more significant effect on specific groups such as males, African Americans, and Hispanic minorities. Treatment of COVID-19 often requires antiviral drugs or monoclonal antibodies. However, immunotherapies such as mesenchymal stem cells and mesenchymal stem cells-derived exosomal vesicles should be evaluated as treatment options for COVID-19. Mesenchymal stem cell therapy offers regenerative, anti-inflammatory, and immunomodulatory properties that can speed up the recovery from COVID-19. Mesenchymal stem cell therapy can also benefit COVID-19 patients who suffer from strokes, as COVID-19 increases the risk of strokes due to increased cytokines and clotting factors. Most stroke cases that occur in COVID-19 patients are ischemic strokes. Therefore, with the help of mesenchymal stem cell therapy and mesenchymal stem cells-derived exosomes, COVID-19-induced stroke patients might benefit from dual-ended treatment. The objective of this review was to discuss COVID-19 and stroke incidence and the available treatment options. |
| first_indexed | 2024-04-09T23:24:04Z |
| format | Article |
| id | doaj.art-5d85cfc9507246b6bc53bce2991c2c70 |
| institution | Directory Open Access Journal |
| issn | 1673-5374 |
| language | English |
| last_indexed | 2024-04-09T23:24:04Z |
| publishDate | 2023-01-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Neural Regeneration Research |
| spelling | doaj.art-5d85cfc9507246b6bc53bce2991c2c702023-03-21T11:23:56ZengWolters Kluwer Medknow PublicationsNeural Regeneration Research1673-53742023-01-011891881188310.4103/1673-5374.367927Use of mesenchymal stem cell therapy in COVID-19 related strokesMahika RawatChiao NgEmaad KhanRayyan A ShahSuha AshfaqGhaith A BahaderZahoor A ShahCoronavirus disease 2019 (COVID-19) has affected a broad demographics, eliciting a more significant effect on specific groups such as males, African Americans, and Hispanic minorities. Treatment of COVID-19 often requires antiviral drugs or monoclonal antibodies. However, immunotherapies such as mesenchymal stem cells and mesenchymal stem cells-derived exosomal vesicles should be evaluated as treatment options for COVID-19. Mesenchymal stem cell therapy offers regenerative, anti-inflammatory, and immunomodulatory properties that can speed up the recovery from COVID-19. Mesenchymal stem cell therapy can also benefit COVID-19 patients who suffer from strokes, as COVID-19 increases the risk of strokes due to increased cytokines and clotting factors. Most stroke cases that occur in COVID-19 patients are ischemic strokes. Therefore, with the help of mesenchymal stem cell therapy and mesenchymal stem cells-derived exosomes, COVID-19-induced stroke patients might benefit from dual-ended treatment. The objective of this review was to discuss COVID-19 and stroke incidence and the available treatment options.http://www.nrronline.org/article.asp?issn=1673-5374;year=2023;volume=18;issue=9;spage=1881;epage=1883;aulast=Rawatcovid-19; cytokines; immunotherapy; interleukin-7; mesenchymal stem cells; neuroinflammation; sex differences; stroke |
| spellingShingle | Mahika Rawat Chiao Ng Emaad Khan Rayyan A Shah Suha Ashfaq Ghaith A Bahader Zahoor A Shah Use of mesenchymal stem cell therapy in COVID-19 related strokes Neural Regeneration Research covid-19; cytokines; immunotherapy; interleukin-7; mesenchymal stem cells; neuroinflammation; sex differences; stroke |
| title | Use of mesenchymal stem cell therapy in COVID-19 related strokes |
| title_full | Use of mesenchymal stem cell therapy in COVID-19 related strokes |
| title_fullStr | Use of mesenchymal stem cell therapy in COVID-19 related strokes |
| title_full_unstemmed | Use of mesenchymal stem cell therapy in COVID-19 related strokes |
| title_short | Use of mesenchymal stem cell therapy in COVID-19 related strokes |
| title_sort | use of mesenchymal stem cell therapy in covid 19 related strokes |
| topic | covid-19; cytokines; immunotherapy; interleukin-7; mesenchymal stem cells; neuroinflammation; sex differences; stroke |
| url | http://www.nrronline.org/article.asp?issn=1673-5374;year=2023;volume=18;issue=9;spage=1881;epage=1883;aulast=Rawat |
| work_keys_str_mv | AT mahikarawat useofmesenchymalstemcelltherapyincovid19relatedstrokes AT chiaong useofmesenchymalstemcelltherapyincovid19relatedstrokes AT emaadkhan useofmesenchymalstemcelltherapyincovid19relatedstrokes AT rayyanashah useofmesenchymalstemcelltherapyincovid19relatedstrokes AT suhaashfaq useofmesenchymalstemcelltherapyincovid19relatedstrokes AT ghaithabahader useofmesenchymalstemcelltherapyincovid19relatedstrokes AT zahoorashah useofmesenchymalstemcelltherapyincovid19relatedstrokes |